TL;DR
Turn quiet afternoons into listening time
- Thousands of audiobooks, podcasts and originals
- Listen on your phone, tablet or Echo — also offline
- Cancel anytime
Intake Breathing received a $62 million investment from Camino Partners, the investment firm founded by Kind Snacks creator Daniel Lubetzky. The company says it will use the funding to expand into physical retail and specialty channels and hire for growth; details about the investment terms and rollout timeline were not disclosed in the source report.
Intake Breathing has received a $62 million investment from Camino Partners, the firm founded by Kind Snacks creator Daniel Lubetzky, as the nasal breathing company prepares to expand beyond online sales into physical retail and specialty channels. The funding is described as the family-run business’s first significant outside capital investment.
Intake makes a magnetic nasal dilator intended to open the nasal passages. Its system uses a reusable magnetic band and adhesive tabs to mechanically open the nasal valve, which the company describes as the narrowest part of the nasal airway. That design differs from traditional adhesive nasal strips. The source report did not provide clinical evidence or independent findings about the device’s effects.
The company has built its business primarily through direct-to-consumer sales. It says it plans to put the investment toward entering physical retail and specialty channels and making key hires to support expansion. The report did not specify how much of the $62 million is allocated to each goal, or which retailers and specialty outlets Intake is targeting.
Intake was founded by inventor and medical device engineer Jim Castillo and is led by his son-in-law, co-founder and chief executive Alex Hauck. Camino’s portfolio also includes Barry’s, a boutique fitness brand, and Athletic Brewing, a nonalcoholic beer maker, according to the report.
Retail Expansion Is the Central Test
The investment gives Intake financial backing as it tries to move from a primarily online business into physical retail, where consumers could encounter the product alongside more familiar nasal-care and wellness goods. Retail expansion can broaden a brand’s reach, but the announcement does not establish how many stores may carry Intake or when sales through those channels will begin.
Camino’s involvement also signals an investor’s bet that nasal breathing products can reach customers beyond a niche audience interested in fitness or performance. Whether shoppers adopt the device as a recurring wellness purchase will depend on factors the announcement does not resolve, including consumer demand, distribution, price and evidence supporting product claims.
For readers, the distinction between the funding news and the product’s performance is important: the $62 million investment is confirmed in the report, while claims about improved breathing, sleep, recovery or athletic performance are not established there by independent research.
Products Worth Considering
Fitbit Versa Smart Watch – Black Aluminum, One Size (S & L Bands Included)
Fitbit Versa 2 Health and Fitness Smartwatch with Bonus Bands
Fitbit Sense Advanced Smartwatch – Sage Grey/Silver (One Size, S & L Bands Included)
As an affiliate, we earn on qualifying purchases.
From Online Sales to Broader Retail
The deal comes amid consumer interest in sleep, recovery and performance optimization, areas that have attracted wellness brands and investors. Intake is seeking to position its nasal device within that market, rather than limiting it to the traditional drugstore category associated with adhesive nasal strips.
The company has drawn attention from professional athletes, including Los Angeles Dodgers pitcher Justin Wrobleski and Belgian soccer player Amadou Onana, the source report said. Their association may raise the product’s profile, but it does not by itself establish that the device improves athletic performance or health outcomes.
Camino’s founder, Daniel Lubetzky, previously created Kind Snacks. Camino says it sees a chance for Intake to help make nasal breathing products a more routine consumer purchase. That is the firm’s investment thesis, not a confirmed forecast of market growth or consumer adoption.
““We’re not just gaining capital, we’re gaining a partner who knows exactly what it takes to help get us there.””
— Alex Hauck, Intake Breathing co-founder and CEO
Deal Terms and Product Evidence
The source report does not state whether the $62 million is an equity investment, debt, or a mix, nor does it disclose valuation, ownership terms or whether the money will arrive in stages. It also gives no timetable for retail launches, names of retail partners, or hiring plans by role or location.
The report describes Intake’s device as designed to open the nasal passages, but it does not cite independent clinical studies or quantify effects on airflow, sleep, recovery or performance. The company’s growth ambitions and Camino’s view of a broader consumer shift should be treated as plans and investment beliefs, not proof of product outcomes or future demand.
Retail Plans and Hiring to Follow
Intake says its next steps are to pursue physical retail and specialty distribution and make key hires. The company has not announced specific stores, launch dates or positions in the source report, so those details remain pending.
Further information about the deal structure, distribution agreements and the evidence behind product performance claims would help clarify how the funding will shape Intake’s business and what consumers can expect. Until the company provides those details, the confirmed development is the investment and its stated expansion plans.
Key Questions
Who invested $62 million in Intake Breathing?
Camino Partners, the investment firm founded by Kind Snacks creator Daniel Lubetzky, made the investment, according to the source report.
What does Intake Breathing sell?
Intake sells a nasal dilator that uses a reusable magnetic band and adhesive tabs to mechanically open the nasal valve. The report does not provide independent clinical findings on its effects.
How does Intake plan to use the funding?
The company says it plans to expand into physical retail and specialty channels and make key hires. A budget breakdown and specific retail partners were not disclosed.
Does the investment prove the device improves sleep or performance?
No. The investment is a business development, not evidence of health or performance outcomes. The source report did not cite independent studies establishing those effects.
Source: athletechnews.com
